Cardiology

Top Story

High CRP predicts long-term mortality, MI after PCI

August 4, 2015

Higher levels of C-reactive protein at the time of PCI were predictive of all-cause mortality and MI at 10 years, researchers reported in a new study.

Researchers studied 468 patients who underwent PCI with a sirolimus-eluting stent for stable CAD or ACS in 2002.

In the Journals

Triple therapy has similar outcomes, more bleeding than dual therapy in older patients

August 4, 2015
Older patients with atrial fibrillation who received triple therapy consisting of aspirin, clopidogrel and warfarin at discharge after PCI for acute MI had a similar…
In the Journals

AHA: Social factors could reverse trend of declining US deaths from heart disease, stroke

August 3, 2015
Social determinants such as education, environment, income and race/ethnicity have the potential to reverse the trend of declining mortality from MI, stroke and other…
In the Journals

Chronic HCV influences subclinical CVD

August 3, 2015
A link between chronic hepatitis C virus infection and subclinical cardiovascular disease indicated a need for thorough and ongoing cardiovascular risk assessments among…
Emily M. Bucholz, MD, MPH In the Journals

Women, black adults face greater loss of life expectancy after MI

August 3, 2015
After an acute MI, black patients lost more of their expected life years than white patients, and women lost more of their expected life years than men, researchers…
More News Headlines »
CME
PCI in ACS: Deciding Among Clopidogrel, Prasugrel, or Ticagrelor

PCI in ACS: Deciding Among Clopidogrel, Prasugrel, or Ticagrelor

This activity is supported by an educational grant from Daiichi Sankyo, Inc. and Lilly USA, LLC

It is estimated that in the United States, each year, over 780,000 persons will experience an acute coronary syndrome…
More »
Video
VIDEO: Joseph Rossano, MD, MS, discusses benefits of VADs for children with advanced HF

VIDEO: Joseph Rossano, MD, MS, discusses benefits of VADs for children with advanced HF

July 17, 2015
PHILADELPHIA — In this video, Joseph Rossano, MD, MS, FAAP, FAAC, medical director of HF/transplantation at…
More »
CME
Highlights from Lipid Forum 2015™: Focus on Hypertriglyceridemia

Highlights from Lipid Forum 2015®: Focus on Hypertriglyceridemia

This activity is supported by an educational grant from AstraZeneca.

Hypertriglyceridemia is a highly prevalent yet modifiable risk factor for atherosclerotic disease, pancreatitis, and…
More »
morganatic-roan